{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:01:59Z","timestamp":1759960919901,"version":"3.44.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jpsychires.2022.03.057","type":"journal-article","created":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T23:23:54Z","timestamp":1649028234000},"page":"202-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Biomarkers as predictors of treatment response to tricyclic antidepressants in major depressive disorder: A systematic review"],"prefix":"10.1016","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7079-8335","authenticated-orcid":false,"given":"Sophie E.","family":"ter Hark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis F.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob E.","family":"Aarnoutse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aart H.","family":"Schene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marieke J.H.","family":"Coenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost G.E.","family":"Janzing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jpsychires.2022.03.057_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.jcp.0000084024.22282.cd","article-title":"Prediction of treatment response in geriatric depression from baseline folate level: interaction with an SSRI or a tricyclic antidepressant","volume":"23","author":"Alpert","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2022.03.057_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s13167-017-0112-8","article-title":"Pharmacogenomics in the treatment of mood disorders: strategies and Opportunities for personalized psychiatry","volume":"8","author":"Amare","year":"2017","journal-title":"EPMA J."},{"year":"2019","series-title":"Guideline Depression 2019","key":"10.1016\/j.jpsychires.2022.03.057_bib3"},{"issue":"Suppl. 1","key":"10.1016\/j.jpsychires.2022.03.057_bib4","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1002\/mpr.216","article-title":"Dimensionality and the category of major depressive episode","volume":"16","author":"Andrews","year":"2007","journal-title":"Int. J. Methods Psychiatr. Res."},{"issue":"Suppl. 15","key":"10.1016\/j.jpsychires.2022.03.057_bib5","first-page":"42","article-title":"SSRI safety in overdose","volume":"59","author":"Barbey","year":"1998","journal-title":"J. Clin. Psychiatr."},{"issue":"3","key":"10.1016\/j.jpsychires.2022.03.057_bib6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1601-5215.2007.00215.x","article-title":"Low red cell folate levels are associated with poor response to nortriptyline in major depression","volume":"19","author":"Beaglehole","year":"2007","journal-title":"Acta Neuropsychiatr."},{"issue":"3","key":"10.1016\/j.jpsychires.2022.03.057_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0165-0327(99)00117-2","article-title":"Effects of antidepressant treatments on polymorphonuclear elastase levels in patients with depression","volume":"59","author":"Bekaroglu","year":"2000","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.jpsychires.2022.03.057_bib8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","article-title":"The bidirectional relationship of depression and inflammation: double trouble","volume":"107","author":"Beurel","year":"2020","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.jpsychires.2022.03.057_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"Biomarkers Definitions Working","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpsychires.2022.03.057_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/3-540-29784-7_20","article-title":"The norepinephrine transporter in physiology and disease","volume":"175","author":"Bonisch","year":"2006","journal-title":"Handb. Exp. Pharmacol."},{"issue":"8","key":"10.1016\/j.jpsychires.2022.03.057_bib11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0924-9338(96)80347-6","article-title":"Genotypes of cytochrome P450 and clinical response to clomipramine in patients with major depression","volume":"10","author":"Bouchez","year":"1995","journal-title":"Eur. Psychiatr."},{"key":"10.1016\/j.jpsychires.2022.03.057_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1741-7015-9-90","article-title":"Cross-national epidemiology of DSM-IV major depressive episode","volume":"9","author":"Bromet","year":"2011","journal-title":"BMC Med."},{"issue":"2","key":"10.1016\/j.jpsychires.2022.03.057_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1522-7162(1996)4:2<73::AID-DEPR6>3.0.CO;2-G","article-title":"Lack of association between thyroid and pineal responses to antidepressant treatment","volume":"4","author":"Brown","year":"1996","journal-title":"Depression"},{"key":"10.1016\/j.jpsychires.2022.03.057_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jad.2015.05.027","article-title":"Neurotrophic factors in depression in response to treatment","volume":"183","author":"Buttenschon","year":"2015","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.jpsychires.2022.03.057_bib15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3109\/08923970009016431","article-title":"Neutrophil peripheral count and human leukocyte elastase during chronic lithium carbonate therapy","volume":"22","author":"Capodicasa","year":"2000","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"3","key":"10.1016\/j.jpsychires.2022.03.057_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/npp.2012.191","article-title":"Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets","volume":"38","author":"Cattaneo","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.jpsychires.2022.03.057_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw045","article-title":"Absolute measurements of macrophage migration inhibitory factor and interleukin-1-beta mRNA levels accurately predict treatment response in depressed patients","volume":"19","author":"Cattaneo","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.jpsychires.2022.03.057_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00427352","article-title":"Urinary 4-hydroxy-3-methoxyphenylglycol is not a predictor for clinical response to amitriptyline in depressive illness","volume":"64","author":"Coppen","year":"1979","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpsychires.2022.03.057_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajp.2017.01.025","article-title":"The neurobiology of depression: an integrated view","volume":"27","author":"Dean","year":"2017","journal-title":"Asian J Psychiatr"},{"issue":"5","key":"10.1016\/j.jpsychires.2022.03.057_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0006-3223(95)00176-X","article-title":"Polymorphonuclear (PMN) elastase levels in depressive disorders","volume":"39","author":"Deger","year":"1996","journal-title":"Biol. Psychiatr."},{"issue":"7","key":"10.1016\/j.jpsychires.2022.03.057_bib21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11920-015-0594-9","article-title":"Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications","volume":"17","author":"Fabbri","year":"2015","journal-title":"Curr. Psychiatr. Rep."},{"issue":"8","key":"10.1016\/j.jpsychires.2022.03.057_bib22","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.euroneuro.2018.05.009","article-title":"Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: meta-analysis of data from genome-wide association studies","volume":"28","author":"Fabbri","year":"2018","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"5","key":"10.1016\/j.jpsychires.2022.03.057_bib23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0006-3223(89)90232-1","article-title":"Dextroamphetamine and dexamethasone suppression test prediction of desipramine response","volume":"25","author":"Faber","year":"1984","journal-title":"Biol. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2022.03.057_bib24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0165-1781(84)90079-9","article-title":"Biological and clinical predictors of response in recurrent depression: a preliminary report","volume":"13","author":"Frank","year":"1994","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2022.03.057_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nbd.2012.05.008","article-title":"Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies","volume":"52","author":"Fu","year":"2013","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.jpsychires.2022.03.057_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0165-0327(90)90142-U","article-title":"Does 24-h urinary MHPG predict treatment response to antidepressants? II. Association between imipramine response and low MHPG","volume":"20","author":"Garvey","year":"1990","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jpsychires.2022.03.057_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0165-0327(86)90055-8","article-title":"The usefulness of DST in predicting response to antidepressants: a placebo-controlled study","volume":"11","author":"Georgotas","year":"1986","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.jpsychires.2022.03.057_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-1781(99)00103-1","article-title":"Platelet alpha2A-adrenoceptor function in major depression: gi coupling, effects of imipramine and relationship to treatment outcome","volume":"89","author":"Gurguis","year":"1995","journal-title":"Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.jpsychires.2022.03.057_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0165-1781(81)90014-7","article-title":"An inverse correlation between serum levels of desmethylimipramine and melatonin-like immunoreactivity in DMI-responsive depressives","volume":"4","author":"Halbreich","year":"1981","journal-title":"Psychiatr. Res."},{"issue":"19\u201320","key":"10.1016\/j.jpsychires.2022.03.057_bib30","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.drudis.2007.07.023","article-title":"PDE inhibitors in psychiatry--future options for dementia, depression and schizophrenia?","volume":"12","author":"Halene","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jpsychires.2022.03.057_bib31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pnpbp.2013.04.009","article-title":"Monoamine neurocircuitry in depression and strategies for new treatments","volume":"45","author":"Hamon","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2022.03.057_bib32","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1177\/0269881109105101","article-title":"Orosomucoid influences the response to antidepressants in major depressive disorder","volume":"24","author":"Harley","year":"2010","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jpsychires.2022.03.057_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2022.03.057_bib34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/0269881113512041","article-title":"Genetic differences in cytochrome P450 enzymes and antidepressant treatment response","volume":"28","author":"Hodgson","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.jpsychires.2022.03.057_bib35","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/jmr.2221","article-title":"Drug-binding energetics of human alpha-1-acid glycoprotein assessed by isothermal titration calorimetry and molecular docking simulations","volume":"25","author":"Huang","year":"2012","journal-title":"J. Mol. Recogn."},{"issue":"1","key":"10.1016\/j.jpsychires.2022.03.057_bib36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1192\/bjp.bp.108.062521","article-title":"Moderation of antidepressant response by the serotonin transporter gene","volume":"195","author":"Huezo-Diaz","year":"2009","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2022.03.057_bib37","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1038\/s41598-018-23584-z","article-title":"Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables","volume":"8","author":"Iniesta","year":"2018","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.jpsychires.2022.03.057_bib38","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1371\/journal.pmed.0020124","article-title":"Why most published research findings are false","volume":"2","author":"Ioannidis","year":"2005","journal-title":"PLoS Med."},{"issue":"5","key":"10.1016\/j.jpsychires.2022.03.057_bib39","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/EDE.0b013e31818131e7","article-title":"Why most discovered true associations are inflated","volume":"19","author":"Ioannidis","year":"2008","journal-title":"Epidemiology"},{"key":"10.1016\/j.jpsychires.2022.03.057_bib40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psyneuen.2017.01.023","article-title":"Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial","volume":"78","author":"Jha","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"12","key":"10.1016\/j.jpsychires.2022.03.057_bib41","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/mp.2012.105","article-title":"Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?","volume":"17","author":"Kapur","year":"2012","journal-title":"Mol. Psychiatr."},{"issue":"7","key":"10.1016\/j.jpsychires.2022.03.057_bib42","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1177\/0269881110376683","article-title":"Variation in GNB3 predicts response and adverse reactions to antidepressants","volume":"25","author":"Keers","year":"2011","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.jpsychires.2022.03.057_bib43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/tpj.2010.14","article-title":"Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project","volume":"11","author":"Keers","year":"2011","journal-title":"Pharmacogenomics J."},{"issue":"13","key":"10.1016\/j.jpsychires.2022.03.057_bib44","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/jama.296.13.1609","article-title":"Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression","volume":"296","author":"Kim","year":"2006","journal-title":"JAMA"},{"issue":"1\u20133","key":"10.1016\/j.jpsychires.2022.03.057_bib45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jad.2012.05.004","article-title":"GTP cyclohydrolase 1 gene haplotypes as predictors of SSRI response in Japanese patients with major depressive disorder","volume":"142","author":"Kishi","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"January 2022","key":"10.1016\/j.jpsychires.2022.03.057_bib46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.euroneuro.2021.09.006","article-title":"Depression and inflammation: correlation between changes in inflammatory markers with antidepressant response and long-term prognosis","volume":"54","author":"Kofod","year":"2022","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.jpsychires.2022.03.057_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6997(25)00015-8","article-title":"Drug binding to human alpha-1-acid glycoprotein in health and disease","volume":"40","author":"Kremer","year":"1988","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.jpsychires.2022.03.057_bib48","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1600-0447.1992.tb10320.x","article-title":"Relationship between parameters of serotonin transport and antidepressant plasma levels or therapeutic response in depressive patients treated with paroxetine and amitriptyline","volume":"85","author":"Kuhs","year":"1992","journal-title":"Acta Psychiatr. Scand."},{"issue":"5","key":"10.1016\/j.jpsychires.2022.03.057_bib49","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1373\/clinchem.2006.066605","article-title":"ABCB1 (P-glycoprotein\/MDR1) gene G2677T\/a sequence variation (polymorphism): lack of association with side effects and therapeutic response in depressed inpatients treated with amitriptyline","volume":"52","author":"Laika","year":"2006","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.jpsychires.2022.03.057_bib50","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4306\/pi.2010.7.4.231","article-title":"The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment","volume":"7","author":"Lee","year":"2010","journal-title":"Psychiatry Investig"},{"key":"10.1016\/j.jpsychires.2022.03.057_bib51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.psychres.2019.06.011","article-title":"Phenotypic analysis of 23andMe survey data: treatment-resistant depression from participants' perspective","volume":"278","author":"Li","year":"2019","journal-title":"Psychiatr. Res."},{"issue":"5","key":"10.1016\/j.jpsychires.2022.03.057_bib52","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/archgenpsychiatry.2009.38","article-title":"Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response","volume":"66","author":"Licinio","year":"2009","journal-title":"Arch. Gen. Psychiatr."},{"issue":"10","key":"10.1016\/j.jpsychires.2022.03.057_bib53","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1176\/ajp.141.10.1159","article-title":"Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs","volume":"141","author":"Maas","year":"1984","journal-title":"Am. J. Psychiatr."},{"issue":"7397","key":"10.1016\/j.jpsychires.2022.03.057_bib54","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/bmj.326.7397.1014","article-title":"Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis","volume":"326","author":"MacGillivray","year":"2003","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.jpsychires.2022.03.057_bib55","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1185\/030079906X132415","article-title":"Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials","volume":"22","author":"Machado","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"issue":"4","key":"10.1016\/j.jpsychires.2022.03.057_bib56","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.biopsych.2010.08.011","article-title":"Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants","volume":"69","author":"Malki","year":"2011","journal-title":"Biol. Psychiatr."},{"issue":"6","key":"10.1016\/j.jpsychires.2022.03.057_bib57","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/0891988718807099","article-title":"Predictors of response and remission to antidepressants in geriatric depression: a systematic review","volume":"31","author":"Masse-Sibille","year":"2018","journal-title":"J. Geriatr. Psychiatr. Neurol."},{"issue":"3","key":"10.1016\/j.jpsychires.2022.03.057_bib58","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/tpj.2010.23","article-title":"A polymorphism of the GTP-cyclohydrolase I feedback regulator gene alters transcriptional activity and may affect response to SSRI antidepressants","volume":"11","author":"McHugh","year":"2011","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.jpsychires.2022.03.057_bib59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fpsyt.2019.00101","article-title":"Is the HPA Axis as target for depression outdated, or is there a new hope?","volume":"10","author":"Menke","year":"2019","journal-title":"Front. Psychiatr."},{"year":"2015","series-title":"TCA (Tricyclische Antidepressiva)","author":"monografie","key":"10.1016\/j.jpsychires.2022.03.057_bib60"},{"issue":"4","key":"10.1016\/j.jpsychires.2022.03.057_bib61","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1440-1819.1997.tb02593.x","article-title":"Effects of genetic defects in the CYP2C19 gene on the N-demethylation of imipramine, and clinical outcome of imipramine therapy","volume":"51","author":"Morinobu","year":"1997","journal-title":"Psychiatr. Clin. Neurosci."},{"issue":"11","key":"10.1016\/j.jpsychires.2022.03.057_bib62","first-page":"1488","article-title":"Value of the DST for predicting response of patients with major depression to hospitalization and desipramine","volume":"147","author":"Nelson","year":"1994","journal-title":"Am. J. Psychiatr."},{"year":"2018","series-title":"Depression in Adults: Treatment and Management","key":"10.1016\/j.jpsychires.2022.03.057_bib63"},{"issue":"2","key":"10.1016\/j.jpsychires.2022.03.057_bib64","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-0327(99)00145-7","article-title":"Alpha-1-acid glycoprotein in major depressive disorder. Relationships to severity, response to treatment and imipramine plasma levels","volume":"59","author":"Nieto","year":"2000","journal-title":"J. Affect. Disord."},{"year":"2013","series-title":"MULTIDISCIPLINAIRE RICHTLIJN DEPRESSIE (3E REVISIE, 2013)","author":"NVvP","key":"10.1016\/j.jpsychires.2022.03.057_bib65"},{"issue":"12","key":"10.1016\/j.jpsychires.2022.03.057_bib66","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1017\/S0033291719001454","article-title":"Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels","volume":"49","author":"Osimo","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpsychires.2022.03.057_bib67","doi-asserted-by":"crossref","first-page":"16065","DOI":"10.1038\/nrdp.2016.65","article-title":"Major depressive disorder","volume":"2","author":"Otte","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"1","key":"10.1016\/j.jpsychires.2022.03.057_bib68","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"10.1016\/j.jpsychires.2022.03.057_bib69","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jad.2018.09.067","article-title":"A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder","volume":"243","author":"Perlman","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.jpsychires.2022.03.057_bib70","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1517\/17425255.2011.597740","article-title":"Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism","volume":"7","author":"Porcelli","year":"2011","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"1","key":"10.1016\/j.jpsychires.2022.03.057_bib71","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/2230-8210.77573","article-title":"Stress and hormones","volume":"15","author":"Ranabir","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jpsychires.2022.03.057_bib72","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-2007-979568","article-title":"Low plasma thyroid indices of depressed patients are attenuated by antidepressant drugs and influence treatment outcome","volume":"29","author":"Rao","year":"1996","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpsychires.2022.03.057_bib73","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.2147\/NDT.S177973","article-title":"Neuroprogression: the hidden mechanism of depression","volume":"14","author":"Ruiz","year":"2018","journal-title":"Neuropsychiatric Dis. Treat."},{"issue":"3","key":"10.1016\/j.jpsychires.2022.03.057_bib74","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/tpj.2009.50","article-title":"The CYP2C19*17 genotype is associated with lower imipramine plasma concentrations in a large group of depressed patients","volume":"10","author":"Schenk","year":"2010","journal-title":"Pharmacogenomics J."},{"issue":"3","key":"10.1016\/j.jpsychires.2022.03.057_bib75","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/15622975.2018.1439595","article-title":"TDM in psychiatry and neurology: a comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup\/&gt","volume":"19","author":"Schoretsanitis","year":"2018","journal-title":"World J. Biol. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2022.03.057_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032438","article-title":"Protein phosphatase magnesium dependent 1A (PPM1A) plays a role in the differentiation and survival processes of nerve cells","volume":"7","author":"Shohat","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jpsychires.2022.03.057_bib77","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.biopsych.2010.04.034","article-title":"Antidepressant response and the serotonin transporter gene-linked polymorphic region","volume":"68","author":"Taylor","year":"2010","journal-title":"Biol. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2022.03.057_bib78","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0893-133X(96)80058-3","article-title":"Is there a relationship between baseline and treatment-associated changes in [3H]-IMI platelet binding and clinical response in major depression?","volume":"14","author":"Tollefson","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jpsychires.2022.03.057_bib79","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1192\/bjp.bp.108.057554","article-title":"Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression","volume":"194","author":"Uher","year":"2009","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2022.03.057_bib80","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/tpj.2009.12","article-title":"Genetic predictors of response to antidepressants in the GENDEP project","volume":"9","author":"Uher","year":"2010","journal-title":"Pharmacogenomics J."},{"issue":"5","key":"10.1016\/j.jpsychires.2022.03.057_bib81","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1176\/appi.ajp.2009.09070932","article-title":"Genome-wide pharmacogenetics of antidepressant response in the GENDEP project","volume":"167","author":"Uher","year":"2010","journal-title":"Am. J. Psychiatr."},{"issue":"12","key":"10.1016\/j.jpsychires.2022.03.057_bib82","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1176\/appi.ajp.2014.14010094","article-title":"An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline","volume":"171","author":"Uher","year":"2014","journal-title":"Am. J. Psychiatr."},{"issue":"18","key":"10.1016\/j.jpsychires.2022.03.057_bib83","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s40265-017-0819-9","article-title":"Progress in elucidating biomarkers of antidepressant pharmacological treatment response: a systematic review and meta-analysis of the last 15 years","volume":"77","author":"Voegeli","year":"2017","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jpsychires.2022.03.057_bib84","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/s12888-021-03490-x","article-title":"Tricyclic antidepressants for major depressive disorder: a comprehensive evaluation of current practice in The Netherlands","volume":"21","author":"Vos","year":"2021","journal-title":"BMC Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2022.03.057_bib85","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/bjd.15753","article-title":"A systematic review of pharmacogenetic studies on the response to biologics in patients with psoriasis","volume":"178","author":"van Vugt","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jpsychires.2022.03.057_bib86","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000356423","article-title":"Stress, memory, and the hippocampus","volume":"34","author":"Wingenfeld","year":"2014","journal-title":"Front Neurol Neurosci"},{"issue":"41","key":"10.1016\/j.jpsychires.2022.03.057_bib87","doi-asserted-by":"crossref","first-page":"15124","DOI":"10.1073\/pnas.0602795103","article-title":"Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response","volume":"103","author":"Wong","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.jpsychires.2022.03.057_bib88","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/YPG.0b013e32834133d2","article-title":"Sequence polymorphisms of MC1R gene and their association with depression and antidepressant response","volume":"21","author":"Wu","year":"2010","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.jpsychires.2022.03.057_bib89","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jad.2019.07.045","article-title":"Inflammatory markers and treatment outcome in treatment resistant depression: a systematic review","volume":"257","author":"Yang","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.jpsychires.2022.03.057_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172270","article-title":"Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression","volume":"12","author":"Zhou","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2022.03.057_bib91","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpsychires.2018.08.011","article-title":"Genetic disposition to inflammation and response to antidepressants in major depressive disorder","volume":"105","author":"Zwicker","year":"2008","journal-title":"J. Psychiatr. Res."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395622001868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395622001868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:29:00Z","timestamp":1758367740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395622001868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":91,"alternative-id":["S0022395622001868"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2022.03.057","relation":{},"ISSN":["0022-3956"],"issn-type":[{"type":"print","value":"0022-3956"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers as predictors of treatment response to tricyclic antidepressants in major depressive disorder: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2022.03.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}